Fuzzy you are right about that - the facts speak for themselves. The well is dry. A Zenith bail out appears to be the most likely funding source for RVX advancement.
So we wait on trial results. Next hurdle is the Hepa debenture. Last years extension came around this time. What will be the verdict this year?